marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 05.11.2024
Apellis Pharmaceuticals Bilanz 2011-2024 | APLS
Bilanz Jährlich Apellis Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-252 M | -453 M | -447 M | -203 M | -195 M | -149 M | -149 M | -24.9 M | -36 M | -13.6 M | -4.76 M | - | - |
Langfristige Schulden |
93 M | 92.7 M | 189 M | 359 M | 143 M | 25.4 M | 26.4 M | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
6.44 M | 5.62 M | 4.12 M | 3.68 M | 2.61 M | 1.67 M | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 289 M | 25.5 M | 26.6 M | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
248 M | 168 M | 132 M | 128 M | 65.8 M | 17 M | 6.55 M | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
594 M | 590 M | 683 M | 756 M | 355 M | 42.6 M | 33.2 M | 3.64 M | 3.2 M | 1.08 M | 677 K | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-2.84 B | -2.31 B | -1.66 B | -926 M | -581 M | -277 M | -149 M | -98.3 M | -71.1 M | -24.6 M | -13.8 M | - | - |
Vermögenswerte |
789 M | 760 M | 882 M | 961 M | 389 M | 204 M | 182 M | 27.4 M | 38.2 M | 14.3 M | 5.2 M | - | - |
Zahlungsmittel |
351 M | 552 M | 640 M | 566 M | 352 M | 176 M | 176 M | 24.9 M | - | - | - | - | - |
Buchwert |
195 M | 170 M | 199 M | 205 M | 34.2 M | 161 M | 149 M | 23.8 M | 35 M | 13.2 M | 4.52 M | - | - |
Gesamtes Eigenkapital |
195 M | 170 M | 199 M | 205 M | 34.2 M | 161 M | 149 M | 23.8 M | 35 M | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Apellis Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
93.3 M | 93.2 M | 93.1 M | 93 M | 93 M | 92.9 M | 92.8 M | 92.7 M | 92.7 M | 189 M | 189 M | 189 M | 190 M | 386 M | 386 M | 359 M | 359 M | 359 M | 359 M | 143 M | 11.3 M | 5.24 M | 5.57 M | - | 27 M | 27 M | 27 M | 27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
665 M | 640 M | 565 M | 594 M | 586 M | 570 M | 567 M | 590 M | 565 M | 668 M | 684 M | 683 M | 583 M | 841 M | 758 M | 756 M | 756 M | 756 M | 756 M | 355 M | 355 M | 355 M | 355 M | 42.6 M | 42.6 M | 42.6 M | 42.6 M | 33.2 M | 33.2 M | 33.2 M | 33.2 M | 3.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-3 B | -2.94 B | -2.9 B | -2.84 B | -2.75 B | -2.61 B | -2.49 B | -2.31 B | -2.14 B | -1.95 B | -1.8 B | -1.66 B | -1.51 B | -1.31 B | -1.09 B | -926 M | -926 M | -926 M | -926 M | -581 M | -581 M | -581 M | -581 M | -277 M | -277 M | -277 M | -277 M | -149 M | -149 M | -149 M | -149 M | -98.3 M | -98.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
902 M | 904 M | 832 M | 789 M | 818 M | 916 M | 979 M | 760 M | 873 M | 1 B | 1.15 B | 882 M | 526 M | 700 M | 810 M | 961 M | 961 M | 961 M | 961 M | 389 M | 389 M | 389 M | 389 M | 204 M | 204 M | 204 M | 204 M | 182 M | 182 M | 182 M | 182 M | 27.4 M | 27.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
397 M | 360 M | 326 M | 351 M | 452 M | 616 M | 765 M | 552 M | 584 M | 604 M | 633 M | 640 M | 284 M | 271 M | 265 M | 567 M | 566 M | 566 M | 566 M | 352 M | 352 M | 352 M | 352 M | 176 M | 176 M | 176 M | 176 M | 176 M | 176 M | 176 M | 176 M | 24.9 M | 24.9 M | - | - | 36 M | - | - | - | 13.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
237 M | 264 M | 267 M | 195 M | 232 M | 345 M | 412 M | 170 M | 307 M | 334 M | 462 M | 199 M | -57.3 M | -141 M | 51.7 M | 205 M | 205 M | 205 M | 205 M | 34.2 M | 34.2 M | 34.2 M | 34.2 M | 161 M | 161 M | 161 M | 161 M | 149 M | 149 M | 149 M | 149 M | 23.8 M | 27.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
237 M | 264 M | 267 M | 195 M | 232 M | 345 M | 412 M | 170 M | 307 M | -334 M | 462 M | 199 M | -57.3 M | -141 M | 51.7 M | 205 M | 205 M | 205 M | 205 M | 34.2 M | 34.2 M | 34.2 M | 34.2 M | 161 M | 161 M | 161 M | 161 M | 149 M | 149 M | 149 M | 149 M | 23.8 M | 23.8 M | - | - | 35 M | - | - | - | 13.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung